|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions

News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia


Market Summary
News
IPOs

Company Profiles

Companies
Events

Research Store

Biotech Events
Post an Event

Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
11/14/2012 8:06:22 AM
How much compensation does Teva Pharmaceuticals pay ceo Jeremy Levin and his executive team? Only their accountants – and a few select insiders – know for sure. Why? The drugmaker claims to adhere to Israeli law, which permits companies with dual stock exchange listings to report these salaries on a group basis, rather than disclose individual sums. However, a pair of Israeli academics, who are also Teva shareholders, are challenging the practice, which the generic drugmaker adopted in 2000, and filed a lawsuit seeking class action status. In their view, Teva is failing to meet basic disclosure requirements and doing shareholders a disservice (here is the lawsuit, although it helps if you read Hebrew). “The result is inconceivable,” Sharon Hannes, a law professor at Tel Aviv University, and Ehud Kamar, who is a law professor at the University of Southern California, write in their complaint. “All US companies and companies traded in Israel give a breakdown of compensation to their senior officers on an individual basis. But Teva, followed by other Israeli dual-listed companies, conceal this information” As noted by Ha’aretz, which first reported their complaint, US law requires information about executive and director pay from domestic and foreign companies that issue securities, but with one exception: compensation can be disclosed on a group basis when laws of a home country do not require reporting on an individual basis.
|
|
|
|
|
|
|
|
|
|
|